SNU-C2A細(xì)胞 
	
		運(yùn)輸方式:	凍存運(yùn)輸
	
	
		數(shù)量:	大量
	
	
		年限:	43 years
	
	
		生長(zhǎng)狀態(tài):	貼壁,多細(xì)胞聚集
	
	
		ATCC Number:	CCL-250.1?
	
	
		相關(guān)**:	大腸癌
	
	
		是否是腫瘤細(xì)胞:	1
	
	
		物種來(lái)源:	人
	
	
		器官來(lái)源:	盲腸
	
	
		細(xì)胞形態(tài):	上皮樣
	
	
		Designations:	SNU-C2A
	
	
		Depositors:	 AF Gazdar
	
	
		SNU-C2A細(xì)胞Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	loosely adherent, multicell aggregates
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	epithelial
	
	
		
	
	
		Source:	Organ: cecum
	
	
		Disease: colorectal carcinoma
	
	
		Cellular Products:	carcinoembryonic antigen (CEA), 5 ng/ml per 10 exp6 cells per 10 days; TAG-72 surface antigen
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Tumorigenic:	Yes
	
	
		Antigen Expression:	Blood type A; Rh+
	
	
		Cytogenetic Analysis: SNU-C2A細(xì)胞modal number = 46; range = 44 to 48.
	
	
		This is a pseudodiploid human cell line. The modal chromosome number is 46, occurring at 86%, with polyploidy at 16.2%. The ins(1;?)(p13;?), del(3)(p23), t(4q,?), t(8;?), del(9)(p13), del(11)(p13), 14q+ and two other marker chromosomes are common to all metaphases examined. Other altered chromosomes, if any, occur only sporadically. Normal N11 is absent. Two copies of X chromosomes are found in each cell. The Y chromosome is not found in QM stained preparations.
	
	
		Isoenzymes:	AK-1, 1
	
	
		ES-D, 1
	
	
		G6PD, B
	
	
		GLO-I, 2
	
	
		Me-2, 2
	
	
		PGM1, 1
	
	
		PGM3, 1
	
	
		Age:	43 years
	
	
		Gender:	female
	
	
		Ethnicity:	Asian
	
	
		Comments:	This is one of 14 colorectal carcinoma cell lines derived by J.G. Park and associates during the years 1982 through 1985.
	
	
		The line was obtained from a third passage nude mouse xenograft of tumor fragments obtained from a patient prior to therapy.
	
	
		SNU-C2A細(xì)胞The line was initially grown in RPMI 1640 medium with 20% fetal bovine serum, but was later adapted to growth in the chemically defined medium ACL-4 (it can also be grown in medium with 10% serum).
	
	
		The cells and tumors formed from the cells produce detectable amounts of Dopa decarboxylase and the TAG-72 antigen.
	
	
		Propagation:	ATCC complete growth medium: ACL-4 medium supplemented with 10% FBS
	
	
		The base medium for this cell line is ATCC-formulated DMEM: F12 Medium Catalog No. 30-2006. To make the complete growth medium, add the following components to the base medium:
	
	
		0.02 mg/ml insulin
	
	
		0.01 mg/ml transferrin
	
	
		25 nM sodium selenite
	
	
		50 nM Hydrocortisone
	
	
		1 ng/ml Epidermal Growth Factor (do not filter)
	
	
		0.01 mM ethanolamine
	
	
		0.01 mM phosphorylethanolamine
	
	
		100 pM triiodothyronine
	
	
		0.5% (w/v) bovine serum albumin
	
	
		10 mM HEPES
	
	
		0.5 mM sodium pyruvate
	
	
		2mM L-glutamine(for final conc. of 4.5 mM)
	
	
		10% FBS
	
	
		
	
	
		Atmosphere: air, 95%; carbon dioxide (CO2), 5%
	
	
		Temperature: 37.0°C
	
	
		Growth Conditions: Growth is slow.
	
	
		Subculturing:	Protocol: Cultures can be maintained by scraping off the attached cells and transfer along with the the floating cells into new flasks.
	
	
		Medium Renewal: Two times weekly
	
	
		Preservation:	Freeze medium: SNU-C2A細(xì)胞Complete growth medium supplemented with an additonal 10% fetal bovine serum and 7.5% (v/v) DMSO
	
	
		Storage temperature: liquid nitrogen vapor phase
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006
	
	
		recommended serum:ATCC 30-2020
	
	
		References:	23066: Park JG, et al. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 47: 6710-6718, 1987. PubMed: 3479249